These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15363569)

  • 1. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment.
    Waldinger MD; Zwinderman AH; Olivier B
    Eur Urol; 2004 Oct; 46(4):510-5; discussion 516. PubMed ID: 15363569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone.
    Waldinger MD; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 2001 Jun; 21(3):293-7. PubMed ID: 11386492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram.
    Waldinger MD; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 2001 Dec; 21(6):556-60. PubMed ID: 11763001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine.
    Waldinger MD; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 2003 Oct; 23(5):467-70. PubMed ID: 14520123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and adequate therapeutic dosage of oral clomipramine for the treatment of premature ejaculation: A randomized, double-blind, placebo-controlled, fixed-dose, parallel-grouped clinical study.
    Kim SW; Choi JB; Kim SJ; Kim KS; Kim CM; Lee DH; Choi WS
    Int J Impot Res; 2018 Apr; 30(2):65-70. PubMed ID: 29203842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).
    McMahon C; Althof S; Rosen R; Giuliano F; Miner M; Osterloh IH; Muirhead GJ; Harty B;
    J Sex Med; 2019 Aug; 16(8):1178-1187. PubMed ID: 31351659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
    Dinsmore WW; Wyllie MG
    BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of On Demand Clomipramine for the Treatment of Premature Ejaculation: A Multicenter, Randomized, Double-Blind, Phase III Clinical Trial.
    Choi JB; Kang SH; Lee DH; Kim YS; Jeon JS; Choi WS; Kim SW
    J Urol; 2019 Jan; 201(1):147-152. PubMed ID: 30086277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.
    Safarinejad MR
    Clin Neuropharmacol; 2006; 29(5):243-52. PubMed ID: 16960468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX).
    Althof S; Osterloh IH; Muirhead GJ; George K; Girard N;
    J Sex Med; 2019 Aug; 16(8):1188-1198. PubMed ID: 31351660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
    Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
    BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis.
    Waldinger MD; Zwinderman AH; Schweitzer DH; Olivier B
    Int J Impot Res; 2004 Aug; 16(4):369-81. PubMed ID: 14961051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: a double-blind, placebo-controlled and randomized study.
    Safarinejad MR
    J Clin Psychopharmacol; 2008 Feb; 28(1):39-44. PubMed ID: 18204339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel on-demand therapy for lifelong premature ejaculation using a miniature transperineal electrical stimulator-the vPatch: an as-treated analysis.
    Shechter A; Mondaini N; Serefoglu EC; Gollan T; Deutsch F; Appel B; Gruenwald I
    J Sex Med; 2023 Jan; 20(1):22-29. PubMed ID: 36897239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of seminal plasma nitric oxide levels and the efficacy of SSRI treatment on lifelong premature ejaculation.
    Kirecci SL; Simsek A; Yuksel A; Gurdal H; Gurbuz ZG; Usanmaz S
    Andrologia; 2014 Dec; 46(10):1169-75. PubMed ID: 24354496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial interventions for premature ejaculation.
    Melnik T; Althof S; Atallah AN; Puga ME; Glina S; Riera R
    Cochrane Database Syst Rev; 2011 Aug; (8):CD008195. PubMed ID: 21833964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study.
    Carson C; Wyllie M
    J Sex Med; 2010 Sep; 7(9):3179-89. PubMed ID: 20584124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Changes in Serum 5-Hydroxy-Tryptamine Concentrations and Improvement in Clinical Symptoms in Primary Premature Ejaculation with Paroxetine Treatment.
    Guo Y; Wang Y; Wang X; Ye G; Jiang Y; Xiong W
    Med Sci Monit; 2015 Aug; 21():2521-7. PubMed ID: 26305631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonresponders to daily paroxetine and another SSRI in men with lifelong premature ejaculation: a pharmacokinetic dose-escalation study for a rare phenomenon.
    Janssen PK; Touw D; Schweitzer DH; Waldinger MD
    Korean J Urol; 2014 Sep; 55(9):599-607. PubMed ID: 25237462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.